Skip to main content
. 2020 Apr 6;12(4):669–683. doi: 10.4168/aair.2020.12.4.669

Fig. 4. Diagnostic models based on enzyme-linked immunosorbent assay and smoking status as covariate for asthma, COPD and lung cancer. (A) ADM vs. healthy controls, (B) CDM vs. healthy controls, (C) LDM vs. healthy controls, (D) LDM vs. COPD patients.

Fig. 4

AUC, area under the curve; ADM, asthma diagnostic model; CDM, COPD diagnostic model; LDM, lung cancer diagnostic model; LDMC, LDM for COPD patients.